Reconstruction of the Fc fragment of the antibody had been shown to eliminate the complications while maintaining the therapeutic effects of the anti-CD40L antibody in SLE and MS mouse models [33, 34]. The gene discussed is CD40LG; the disease is myeloid sarcoma.